Literature DB >> 9510318

Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases.

H M van Dullemen1, E de Jong, F Slors, G N Tytgat, S J van Deventer.   

Abstract

PURPOSE: Two young females with well-documented Crohn's disease and nonhealing perineal wounds following proctectomy compatible with "metastatic Crohn's disease" are described. We hypothesized that metastatic Crohn's disease would be a tumor necrosis factor-dependent inflammatory reaction and have treated these two patients with the anti-tumor necrosis factor chimeric monoclonal antibody, cA2. MAIN
FINDINGS: Administration of cA2 was followed by a rapid reduction of subjective and objective parameters of inflammation and caused a substantial reduction of the wound size.
CONCLUSION: These preliminary data are consistent with a tumor necrosis factor-dependent inflammatory cause of Crohn's disease and its extraintestinal manifestations and provide support for targeting tumor necrosis factor in this condition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510318     DOI: 10.1007/BF02236903

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  New biologic agents: a critical appraisal.

Authors:  B E Sands
Journal:  Curr Gastroenterol Rep       Date:  1999-12

3.  Metastatic Crohn's disease of the face.

Authors:  Deborah B Graham; David L Jager; Marie L Borum
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

4.  Metastatic Crohn's disease of the ear.

Authors:  J H Chuah; D S Kim; C Allen; L Hollis
Journal:  Int J Otolaryngol       Date:  2009-03-16

Review 5.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012

6.  Metastatic Crohn's disease despite infliximab therapy.

Authors:  Sara Campos; Inês Coutinho; José Carlos Cardoso; Francisco Portela
Journal:  An Bras Dermatol       Date:  2017       Impact factor: 1.896

Review 7.  Metastatic Crohn's Disease: An Approach to an Uncommon but Important Cutaneous Disorder.

Authors:  Babak Aberumand; Jessica Howard; John Howard
Journal:  Biomed Res Int       Date:  2017-01-03       Impact factor: 3.411

8.  Wound healing of metastatic perineal Crohn's disease using hyperbaric oxygen therapy: A case series.

Authors:  Corine A Lansdorp; Christianne J Buskens; Krisztina B Gecse; Geert Ram D'Haens; Rob A Van Hulst
Journal:  United European Gastroenterol J       Date:  2020-06-12       Impact factor: 4.623

9.  Metastatic Crohn's disease of external genitalia.

Authors:  Charles Panackel; Joseph John; Devadas Krishnadas; Kattoor R Vinayakumar
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

10.  Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.

Authors:  Christine M Costello; Nancy Mah; Robert Häsler; Philip Rosenstiel; Georg H Waetzig; Andreas Hahn; Tim Lu; Yesim Gurbuz; Susanna Nikolaus; Mario Albrecht; Jochen Hampe; Ralph Lucius; Günther Klöppel; Holger Eickhoff; Hans Lehrach; Thomas Lengauer; Stefan Schreiber
Journal:  PLoS Med       Date:  2005-08-23       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.